Trial Details
COMPLETEDBasic Information
| Clinical ID | c34 |
|---|---|
| Identifier | NCT01971814 |
| Trial Title | Early Serum Infliximab Levels in Severe Ulcerative Colitis. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC)|Inflammatory Bowel Disease |
| Interventions | DRUG: Infliximab |
Participant Information
| Sponsor | University of California, San Francisco |
|---|---|
| City | San Francisco |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-11-13 |
|---|---|
| Primary Completion Date | 2025-01-15 |
| Completion Date | 2025-01-15 |